Literature DB >> 30798598

Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota.

Yizhe Cui1, Qiuju Wang1, Renxu Chang1, Xiaocui Zhou2, Chuang Xu1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress liver injury that is closely related to obesity, insulin resistance, type 2 diabetes, atherosclerosis, and metabolic syndrome. The pathological features are diffuse hepatic vesicular steatosis, including non-alcoholic steatohepatitis, liver fibrosis, and even liver cancer. A variety of pathological outcomes cause serious harm to human health. At present, an increasing number of researchers are investigating the pathogenesis of NAFLD from the perspective of changes in the function of the intestinal barrier. The physical, chemical, immunological, and microbiological barriers in the intestinal tract constitute the complete intestinal barrier, which plays an important defensive role against the invasion of harmful substances from the intestines. Protecting the function of the intestinal barrier is a new way to treat NAFLD and its related diseases. In this perspective, we summarized the current knowledge of the role of the intestinal barrier in NAFLD.

Entities:  

Keywords:  NAFLD; barrier function; gut−liver axis; intestinal microflora; oxidative stress

Mesh:

Year:  2019        PMID: 30798598     DOI: 10.1021/acs.jafc.9b00080

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  21 in total

1.  Mixture of blackberry leaf and fruit extracts alleviates non-alcoholic steatosis, enhances intestinal integrity, and increases Lactobacillus and Akkermansia in rats.

Authors:  Sunmin Park; Song Mi Cho; Bo Ram Jin; Hye Jeong Yang; Qiu Jing Yi
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-21

Review 2.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

Review 3.  A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.

Authors:  Wangxin Liu; Xianliang Luo; Jun Tang; Qiufen Mo; Hao Zhong; Hui Zhang; Fengqin Feng
Journal:  Eur J Nutr       Date:  2020-11-12       Impact factor: 5.614

4.  Effects of Taraxacum mongolicum Hand.-Mazz. (dandelion) on growth performance, expression of genes coding for tight junction protein and mucin, microbiota composition and short chain fatty acids in ileum of broiler chickens.

Authors:  Jinju Mao; Yuan Wang; Wenwen Wang; Ting Duan; Na Yin; Tao Guo; Hui Guo; Na Liu; Xiaoping An; Jingwei Qi
Journal:  BMC Vet Res       Date:  2022-05-14       Impact factor: 2.792

5.  Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate.

Authors:  Ruiqing Wang; Xinyu Yang; Jinting Liu; Fang Zhong; Chen Zhang; Yuhong Chen; Tao Sun; Chunyan Ji; Daoxin Ma
Journal:  Nat Commun       Date:  2022-05-09       Impact factor: 17.694

6.  Ufbp1, a Key Player of Ufm1 Conjugation System, Protects Against Ketosis-Induced Liver Injury via Suppressing Smad3 Activation.

Authors:  Fanghui Chen; Le Sheng; Chenjie Xu; Jun Li; Ilyas Ali; Honglin Li; Yafei Cai
Journal:  Front Cell Dev Biol       Date:  2021-07-08

7.  Pediococcus pentosaceus xy46 Can Absorb Zearalenone and Alleviate its Toxicity to the Reproductive Systems of Male Mice.

Authors:  Shuhua Yang; Ping Gong; Jianwen Pan; Nan Wang; Jingjing Tong; Mingyang Wang; Miao Long; Peng Li; Jianbin He
Journal:  Microorganisms       Date:  2019-08-16

8.  Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.

Authors:  Bingyu Shen; Haihua Feng; Jiaqi Cheng; Zheng Li; Meiyu Jin; Lilei Zhao; Qi Wang; Haiyan Qin; Guowen Liu
Journal:  J Cell Mol Med       Date:  2020-04-15       Impact factor: 5.310

9.  Non-esterified Fatty Acid Induce Dairy Cow Hepatocytes Apoptosis via the Mitochondria-Mediated ROS-JNK/ERK Signaling Pathway.

Authors:  Yu Li; Hongyan Ding; Leihong Liu; Yuxiang Song; Xiliang Du; Shibin Feng; Xichun Wang; Xiaobing Li; Zhe Wang; Xinwei Li; Jinchun Li; Jinjie Wu; Guowen Liu
Journal:  Front Cell Dev Biol       Date:  2020-04-28

10.  Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.

Authors:  Ling Zhou; Zhexin Ni; Jin Yu; Wen Cheng; Zailong Cai; Chaoqin Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.